Elsevier

Microvascular Research

Volume 59, Issue 1, January 2000, Pages 88-98
Microvascular Research

Regular Article
Endothelin and Free Radicals Modulate Microvascular Responses in Streptozotocin-Induced Diabetic Rats

https://doi.org/10.1006/mvre.1999.2209Get rights and content

Abstract

The quantitative contribution of endothelin and free radicals in modulating peripheral endothelial and smooth muscle-dependent vascular responses in 4 weeks streptozotocin-induced diabetic rats was investigated. Skin blood flow was monitored in base of blisters raised on the hind footpad. Smooth muscle-dependent vasodilation was tested using sodium nitroprusside (SNP). Endothelial-mediated inflammatory responses were induced via either electrical stimulation (ES) of the sciatic nerve or substance P (SP) perfusion over the blister base. Role of endothelin and free radicals was examined using ET-A or ET-B receptor antagonists (BQ-123 or BQ-788) and superoxide anions or hydroxyl radicals scavengers (superoxide dismutase (SOD) or N-acetyl cysteine (NAC)). Diabetic rats showed a significant reduction (75%) in SNP responses that coincided with a 70 and 60% reduction in responses to ES and SP. Their basal plasma extravasation (PE) was significantly higher while PE response to SP was significantly reduced. BQ-788, was more potent than BQ-123, improving responses to ES and SP in diabetic rats by 85%. Likewise, NAC was more potent than SOD normalizing the ES response and improving SP response by 85%. Combined treatment with BQ-123 and SOD normalized all vasodilatation responses in diabetic rats. BQ-123 and BQ-788 were equally potent normalizing the PE responses to SP whereas SOD and NAC had no effect. We conclude that endothelin and free radicals play a role in altering microvascular function in diabetes and that their effect could be reversed early in the disease.

References (37)

  • L. Vesci et al.

    Cardiac and renal endothelin-1 binding sites in streptozotocin-induced diabetic rats

    Pharmacol. Res.

    (1995)
  • P.V. Andrews et al.

    NK1 receptor mediation of neurogenic plasma extravasation in rat skin

    Br. J. Pharmacol.

    (1989)
  • C.R.W. Bell et al.

    The density and distribution of endotehlin-1 and endothelin receptor subtypes in normal and diabetic rat corpus cavenosum

    Br. J. Urol.

    (1995)
  • G.S. Bennett et al.

    Neurogenic cutaneous vasodilatation and plasma extravasation in diabetic rats: Effect of insulin and nerve growth factor

    Br. J. Pharmacol.

    (1998)
  • D. Diederich et al.

    Endothelial dysfunction in mesenteric arteries of diabetic rats: Role of free radicals

    Am. J. Physiol.

    (1994)
  • R.M. Edwards et al.

    Characterization of 125l-endothelin-1 binding to rat and rabbit renal microvasculature

    J. Pharmacol. Exp. Ther.

    (1995)
  • L.E. Franzen et al.

    Impaired connective tissue repair in streptozotocin-induced diabetes shows ultrastructural signs of impaired contraction

    J. Surg. Res.

    (1995)
  • D. Giugliano et al.

    oxidative stress and diabetic vascular complications

    Diabetes Care

    (1996)
  • Cited by (22)

    • Short- and long-term modulation of microvascular responses in streptozotocin-induced diabetic rats by glycosylated products

      2010, Journal of Diabetes and its Complications
      Citation Excerpt :

      However, occasionally, some rats lost close to 15% of their body mass due to the severity of diabetes, and these (n=1–2) rats were given insulin treatment (2 IU/100 g, sc, once or twice only) to give them respite from the catabolic dominance of diabetes while allowing regular and severe hyperglycemia. We previously showed a significant reduction in average weight gain, BBF, and responses to SP and SNP in diabetic rats over the experimental period (4 weeks) (Bassirat & Khalil, 2000). The average weight gain in normal rats was 30.1 g/week compared to only 8.8 g/week in diabetic rats during this period (data not shown).

    • The effect of N-acetylcysteine on cardiac contractility to dobutamine in rats with streptozotocin-induced diabetes

      2005, European Journal of Pharmacology
      Citation Excerpt :

      Chronic treatment of alloxan-induced diabetic mice with N-acetylcysteine reduced the activation of the nuclear transcription factor-κB in the pancreas, and this has the potential of reducing the production of proinflammatory cytokines such as interleukins and inducible nitric oxide synthase (Ho et al., 1999). Acute administration of N-acetylcysteine also improved vasodilatation response to electrical stimulation or to substance P in rats with streptozotocin-induced diabetes (Bassirat and Khalil, 2000). Chronic treatment with N-acetylcysteine prevented the development of peripheral neuropathy in streptozotocin-induced diabetic rats (Sagara et al., 1996), as well as ultrastructure changes in the erythrocytes of patients with type II diabetes (Straface et al., 2002).

    View all citing articles on Scopus
    View full text